China GMP
Form: capsule
Strength: 100mg
Indication: Chronic myeloid leukaemia (CML); Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph-positive ALL)
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This product category refers to **oral pharmaceutical capsules** formulated as **imatinib mesylate**, a tyrosine kinase inhibitor. Manufactured under strict **GMP standards**, these dosage units utilize **pharmaceutical-grade polymers** and **excipients** to ensure stability and bioavailability for systemic delivery.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Centers:</strong> Primary treatment for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).</li>
<li><strong>Hematology Departments:</strong> Management of Philadelphia chromosome-positive acute lymphoblastic leukemia.</li>
<li><strong>Specialized Pharmacies:</strong> Bulk procurement for hospital formulary distribution and patient dispensing programs.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Maintain in controlled environments with humidity below 60% to prevent capsule degradation.</li>
<li><strong>Handling:</strong> Personnel must use protective gear to avoid direct skin contact during bulk unpacking.</li>
<li><strong>Inspection:</strong> Conduct periodic quality checks for moisture ingress or physical deformation before distribution.</li>
</ul>